MedTrace Logo

The PERSEVERE Study

NCT06588634 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2026-05-08

No results posted yet for this study

Summary

Randomized Controlled Trial of High-Risk Pulmonary Embolism Comparing FlowTriever System vs. Standard of Care

Conditions

Interventions

DEVICE

FlowTriever System

Mechanical thrombectomy for pulmonary embolism

PROCEDURE

Standard of Care

Standard of care treatment for pulmonary embolism

Sponsors & Collaborators

  • Inari Medical

    lead INDUSTRY

Principal Investigators

  • Nicolas Meneveau, MD PhD · Centre Hospitalier Universitaire Hôpital Jean Minjoz, Besançon, France

  • Stavros Konstantinides, MD PhD · Center for Thrombosis and Hemostasis, University Medical Center of the Johannes Gutenberg-University Mainz, Germany

  • John M Moriarty, MD · Westwood Imaging Center & Interventional Radiology Clinic - UCLA, CA, USA

  • Jay Giri, MD, MPH · Penn Medicine, Philadelphia, PA, USA

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-12-16
Primary Completion
2027-11-30
Completion
2028-02-29
FDA Device
Yes

Countries

  • United States
  • France
  • Germany
  • Spain
  • Switzerland
  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06588634 on ClinicalTrials.gov